A citation-based method for searching scientific literature

Dimitrios Giannis, Dimitrios Moris, Andrew S Barbas. Cancers (Basel) 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
Wantong Yao, Johnathon L Rose, Wei Wang, Sahil Seth, Hong Jiang, Ayumu Taguchi, Jintan Liu, Liang Yan, Avnish Kapoor, Pingping Hou,[...]. Nature 2019
57
50

Endothelial heparan sulfate in angiogenesis.
Mark M Fuster, Lianchun Wang. Prog Mol Biol Transl Sci 2010
50
50

Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer.
Xin Huang, Chengqi Fan, Huanhuan Zhu, Wenjun Le, Shaobin Cui, Xin Chen, Wei Li, Fulei Zhang, Yong Huang, Donglu Sh,[...]. Int J Nanomedicine 2018
10
50

HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.
Jin-Ping Lai, Jeremy Chien, Scott E Strome, Julie Staub, Damian P Montoya, Eddie L Greene, David I Smith, Lewis R Roberts, Viji Shridhar. Oncogene 2004
109
50

The Role of Glypican-1 in the Tumour Microenvironment.
Maria E Lund, Douglas H Campbell, Bradley J Walsh. Adv Exp Med Biol 2020
14
50

Nerve-cancer interactions in the stromal biology of pancreatic cancer.
Ihsan Ekin Demir, Helmut Friess, Güralp O Ceyhan. Front Physiol 2012
64
50

The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy.
K Dredge, E Hammond, K Davis, C P Li, L Liu, K Johnstone, P Handley, N Wimmer, T J Gonda, A Gautam,[...]. Invest New Drugs 2010
78
50

Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells.
Lorenzo Depau, Jlenia Brunetti, Chiara Falciani, Elisabetta Mandarini, Giulia Riolo, Marta Zanchi, Evgenia Karousou, Alberto Passi, Alessandro Pini, Luisa Bracci. J Med Chem 2020
3
50

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. World J Gastroenterol 2018
406
50

Exosomes and pancreatic diseases: status, challenges, and hopes.
Xiao-Yu Guo, Fan Xiao, Jie Li, Yi-Nan Zhou, Wang-Jun Zhang, Bei Sun, Gang Wang. Int J Biol Sci 2019
13
50

hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.
Jin-Ping Lai, Jeremy R Chien, David R Moser, Julie K Staub, Ileana Aderca, Damian P Montoya, Tori A Matthews, David M Nagorney, Julie M Cunningham, David I Smith,[...]. Gastroenterology 2004
119
50

Non-Anticoagulant Heparins as Heparanase Inhibitors.
Giuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi. Adv Exp Med Biol 2020
16
50


The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma.
Stuart M Robinson, Lavender Fan, Steven A White, Richard M Charnley, Jelena Mann. Int J Biochem Cell Biol 2016
11
50


Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.
Andrew V Biankin, Nicola Waddell, Karin S Kassahn, Marie-Claude Gingras, Lakshmi B Muthuswamy, Amber L Johns, David K Miller, Peter J Wilson, Ann-Marie Patch, Jianmin Wu,[...]. Nature 2012
50

SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression.
Roop M S Gill, Andreas Michael, Leah Westley, Hemant M Kocher, Joshua I Murphy, Gurtej K Dhoot. Exp Cell Res 2014
14
50

A guide to the composition and functions of the extracellular matrix.
Nikos K Karamanos, Achilleas D Theocharis, Zoi Piperigkou, Dimitra Manou, Alberto Passi, Spyros S Skandalis, Demitrios H Vynios, Véronique Orian-Rousseau, Sylvie Ricard-Blum, Christian E H Schmelzer,[...]. FEBS J 2021
13
50

Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy.
Monica Galli, Manik Chatterjee, Mariella Grasso, Giorgina Specchia, Hila Magen, Hermann Einsele, Ivana Celeghini, Paola Barbieri, David Paoletti, Silvia Pace,[...]. Haematologica 2018
58
50

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.
Yafei Li, Chau-Chyun Sheu, Yuanqing Ye, Mariza de Andrade, Liang Wang, Shen-Chih Chang, Marie C Aubry, Jeremiah A Aakre, Mark S Allen, Feng Chen,[...]. Lancet Oncol 2010
164
50

Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases.
Nikos K Karamanos, Achilleas D Theocharis, Thomas Neill, Renato V Iozzo. Matrix Biol 2019
121
50

Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma.
Amichay Meirovitz, Esther Hermano, Immanuel Lerner, Eyal Zcharia, Claudio Pisano, Tamar Peretz, Michael Elkin. Cancer Res 2011
53
50

Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Takahiko Nishigaki, Tsuyoshi Takahashi, Satoshi Serada, Minoru Fujimoto, Tomoharu Ohkawara, Hisashi Hara, Takahito Sugase, Toru Otsuru, Yurina Saito, Shigehiro Tsujii,[...]. Br J Cancer 2020
12
50




Syndecans and Pancreatic Ductal Adenocarcinoma.
Nausika Betriu, Juan Bertran-Mas, Anna Andreeva, Carlos E Semino. Biomolecules 2021
1
100

HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.
Kenji Uchimura, Megumi Morimoto-Tomita, Annette Bistrup, Jessica Li, Malcolm Lyon, John Gallagher, Zena Werb, Steven D Rosen. BMC Biochem 2006
165
50

Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer.
Yu Mu, Dezhi Wang, Liangyu Bie, Suxia Luo, Xiaoqian Mu, Yanqiu Zhao. Aging (Albany NY) 2020
2
50

Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Israel Vlodavsky, Preeti Singh, Ilanit Boyango, Lilach Gutter-Kapon, Michael Elkin, Ralph D Sanderson, Neta Ilan. Drug Resist Updat 2016
118
50


Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.
Dong Xiao, Zhanjun Dong, Linqing Zhen, Guanggai Xia, Xinyu Huang, Tiezhong Wang, Huaibin Guo, Binhui Yang, Cheng Xu, Weiwei Wu,[...]. Mol Cancer Res 2020
10
50

A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.
J Wijdenes, W C Vooijs, C Clément, J Post, F Morard, N Vita, P Laurent, R X Sun, B Klein, J M Dore. Br J Haematol 1996
294
50

A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy.
Wenli Qiu, Huifeng Zhang, Xiao Chen, Lina Song, Wenjing Cui, Shuai Ren, Yajie Wang, Kai Guo, Donghui Li, Rong Chen,[...]. Nanomedicine (Lond) 2019
10
50


Pancreatic cancer stroma: friend or foe?
Jesse Gore, Murray Korc. Cancer Cell 2014
120
50

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Sonia A Melo, Linda B Luecke, Christoph Kahlert, Agustin F Fernandez, Seth T Gammon, Judith Kaye, Valerie S LeBleu, Elizabeth A Mittendorf, Juergen Weitz, Nuh Rahbari,[...]. Nature 2015
50

Proteoglycans in health and disease: the multiple roles of syndecan shedding.
Tina Manon-Jensen, Yoshifumi Itoh, John R Couchman. FEBS J 2010
189
50

Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer.
Jun Yao, Lu-Lin Zhang, Xu-Mei Huang, Wen-Yao Li, She-Gan Gao. World J Gastroenterol 2017
14
50

Hsulf-1 regulates growth and invasion of pancreatic cancer cells.
I Abiatari, J Kleeff, J Li, K Felix, M W Büchler, H Friess. J Clin Pathol 2006
28
50

Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth.
T Kinnunen, M Kaksonen, J Saarinen, N Kalkkinen, H B Peng, H Rauvala. J Biol Chem 1998
184
50

Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer.
Amanda MacDonald, Michelle Priess, Jennifer Curran, Jamey Guess, Victor Farutin, Ilse Oosterom, Chia Lin Chu, Edward Cochran, Lynn Zhang, Kristen Getchell,[...]. Mol Cancer Ther 2019
10
50

Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds.
Chakrabhavi Dhananjaya Mohan, Swetha Hari, Habbanakuppe D Preetham, Shobith Rangappa, Uri Barash, Neta Ilan, S Chandra Nayak, Vijai K Gupta, Basappa, Israel Vlodavsky,[...]. iScience 2019
32
50

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
Agnieszka K Witkiewicz, Elizabeth A McMillan, Uthra Balaji, GuemHee Baek, Wan-Chi Lin, John Mansour, Mehri Mollaee, Kay-Uwe Wagner, Prasad Koduru, Adam Yopp,[...]. Nat Commun 2015
588
50

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma.
Sundar Jagannath, Leonard T Heffner, Sikander Ailawadhi, Nikhil C Munshi, Todd M Zimmerman, Jacalyn Rosenblatt, Sagar Lonial, Asher Chanan-Khan, Markus Ruehle, Faiza Rharbaoui,[...]. Clin Lymphoma Myeloma Leuk 2019
39
50

A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
Xianyin Lai, Mu Wang, Samantha Deitz McElyea, Stuart Sherman, Michael House, Murray Korc. Cancer Lett 2017
162
50

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
50

Glypican-1 circulating exosomes: a promising clue to individualize surveillance of pancreatic cysts?
Pedro Moutinho-Ribeiro, Sonia Melo, Guilherme Macedo. Eur Radiol 2018
5
50

Glypican-5 is a tumor suppressor in non-small cell lung cancer cells.
Lixia Guo, Jingyu Wang, Ting Zhang, Yanan Yang. Biochem Biophys Rep 2016
11
50

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.